APA (7th ed.) Citation

Lin, H., Subbiah, V., Fu, S., Naing, A., Nicholas, C., Pant, S., . . . Proia, T. Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Lin, Heather, et al. Preclinical Study and Parallel Phase II Trial Evaluating Antisense STAT3 Oligonucleotide and Checkpoint Blockade for Advanced Pancreatic, Non-small Cell Lung Cancer and Mismatch Repair-deficient Colorectal Cancer. BMJ Publishing Group.

MLA (9th ed.) Citation

Lin, Heather, et al. Preclinical Study and Parallel Phase II Trial Evaluating Antisense STAT3 Oligonucleotide and Checkpoint Blockade for Advanced Pancreatic, Non-small Cell Lung Cancer and Mismatch Repair-deficient Colorectal Cancer. BMJ Publishing Group.